Biosil® was introduced for sale in the USA in 1994 and meets or exceeds all FDA requirements for dietary supplements. The FDA inspects our manufacturing facility in Belgium, and also inspects and approves Biosil® products for sale upon their arrival in the USA. The FDA reviews all of our claims substantiations, ingredients and safety practices prior to approving our products.

In Europe, the European Food Safety Authority, considered by many to be one of the most stringent review panels in the world, has reviewed and approved ch-OSA®. Their written opinion deeming ch-OSA® safe and bioavailable can be found online here.

In Canada, Health Canada's rigorous new regulatory program has granted Biosil® products Natural Product Numbers after evaluating our scientific support, and confirming safety and claims substantiation (Biosil® Capsules: NPN 80023605; Biosil® Liquid Drops: NPN 800005878.)